215 related articles for article (PubMed ID: 8930579)
1. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
van der Reijden WA; van der Kwaak JS; Veerman EC; Nieuw Amerongen AV
Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):335-40. PubMed ID: 8930579
[TBL] [Abstract][Full Text] [Related]
2. Effect of periodontal treatment on the protein composition of whole and parotid saliva.
Henskens YM; van der Weijden FA; van den Keijbus PA; Veerman EC; Timmerman MF; van der Velden U; Amerongen AV
J Periodontol; 1996 Mar; 67(3):205-12. PubMed ID: 8708950
[TBL] [Abstract][Full Text] [Related]
3. Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA.
Henskens YM; van den Keijbus PA; Veerman EC; Van der Weijden GA; Timmerman MF; Snoek CM; Van der Velden U; Nieuw Amerongen AV
J Periodontal Res; 1996 Jan; 31(1):57-65. PubMed ID: 8636877
[TBL] [Abstract][Full Text] [Related]
4. Sialochemical markers of salivary gland involvement with Sjögren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis.
Carpenter GH; Proctor GB; Pankhurst CL; O'Donohue J; Scott D; Hunnable MP
J Oral Pathol Med; 2000 Oct; 29(9):452-9. PubMed ID: 11016688
[TBL] [Abstract][Full Text] [Related]
5. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
[TBL] [Abstract][Full Text] [Related]
6. s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study.
Rhodus N; Dahmer L; Lindemann K; Rudney J; Mathur A; Bereuter J
Clin Oral Investig; 1998 Dec; 2(4):191-6. PubMed ID: 10388393
[TBL] [Abstract][Full Text] [Related]
7. Clinical utilization of sialochemistry in Sjögren's syndrome.
Stuchell RN; Mandel ID; Baurmash H
J Oral Pathol; 1984 Jun; 13(3):303-9. PubMed ID: 6204031
[TBL] [Abstract][Full Text] [Related]
8. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
9. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
[TBL] [Abstract][Full Text] [Related]
10. Salivary protein composition in epileptic patients on different medications.
Henskens YM; Strooker H; van den Keijbus PA; Veerman EC; Nieuw Amerongen AV
J Oral Pathol Med; 1996 Aug; 25(7):360-6. PubMed ID: 8890049
[TBL] [Abstract][Full Text] [Related]
11. Protein and mucin retention on oral mucosal surfaces in dry mouth patients.
Pramanik R; Osailan SM; Challacombe SJ; Urquhart D; Proctor GB
Eur J Oral Sci; 2010 Jun; 118(3):245-53. PubMed ID: 20572857
[TBL] [Abstract][Full Text] [Related]
12. Indicators of salivary gland inflammation in primary Sjogren's syndrome.
Cuida M; Halse AK; Johannessen AC; Tynning T; Jonsson R
Eur J Oral Sci; 1997 Jun; 105(3):228-33. PubMed ID: 9249189
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the relationship between passive smoking and salivary electrolytes, protein, secretory IgA, sialic acid and amylase in young children.
Avşar A; Darka O; Bodrumlu EH; Bek Y
Arch Oral Biol; 2009 May; 54(5):457-63. PubMed ID: 19249013
[TBL] [Abstract][Full Text] [Related]
14. Two-dimensional electrophoresis of human salivary proteins from patients with sialoadenopathy.
Mogi M; Harada M; Kage T; Chino T; Yoshitake K
Arch Oral Biol; 1993 Dec; 38(12):1135-9. PubMed ID: 8141677
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody synthesis in salivary glands of Sjögren's syndrome patients.
Horsfall AC; Rose LM; Maini RN
J Autoimmun; 1989 Aug; 2(4):559-68. PubMed ID: 2789658
[TBL] [Abstract][Full Text] [Related]
16. Primary Sjögren's syndrome: salivary gland function and clinical oral findings.
Pedersen AM; Reibel J; Nordgarden H; Bergem HO; Jensen JL; Nauntofte B
Oral Dis; 1999 Apr; 5(2):128-38. PubMed ID: 10522209
[TBL] [Abstract][Full Text] [Related]
17. Progression of salivary gland dysfunction in patients with Sjogren's syndrome.
Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A
Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458
[TBL] [Abstract][Full Text] [Related]
18. Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome.
Martini D; Gallo A; Vella S; Sernissi F; Cecchettini A; Luciano N; Polizzi E; Conaldi PG; Mosca M; Baldini C
Rheumatology (Oxford); 2017 Jun; 56(6):1031-1038. PubMed ID: 28339625
[TBL] [Abstract][Full Text] [Related]
19. Salivary β2-microglobulin positively correlates with ESSPRI in patients with primary Sjögren's syndrome.
Garza-García F; Delgado-García G; Garza-Elizondo M; Ceceñas-Falcón LÁ; Galarza-Delgado D; Riega-Torres J
Rev Bras Reumatol Engl Ed; 2017; 57(2):182-184. PubMed ID: 28343624
[No Abstract] [Full Text] [Related]
20. Sialochemistry and cortisol levels in patients with Sjogren's syndrome.
Miller BE; Deutsch O; Redlich M; Konttinen YT; Benoliel R; Zaks B; Davidovich E; Palmon A; Aframian DJ
Oral Dis; 2012 Apr; 18(3):255-9. PubMed ID: 22050355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
